4
Changes in Ownership
10x Genomics, Inc. Filed Acc 0001209191-21-007560
Chief Financial Officer sold 10,000 shares at an average $176.05 ($1,760,479)
- Chief Financial Officer acquired 10,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
McAnear Justin J. · Chief Financial Officer
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-02-01 | Exercise or conversion : show line 1 in the form | +10,000 | $5.04 | $50,400 | 30,774 | D |
| 2021-02-01 | Sale : show line 2 in the form | −600 | $174.18 | $104,509 | 30,174 | D |
| 2021-02-01 | Sale : show line 3 in the form | −5,213 | $175.53 | $915,027 | 24,961 | D |
| 2021-02-01 | Sale : show line 4 in the form | −2,777 | $176.51 | $490,171 | 22,184 | D |
| 2021-02-01 | Sale : show line 5 in the form | −910 | $177.50 | $161,525 | 21,274 | D |
| 2021-02-01 | Sale : show line 6 in the form | −500 | $178.49 | $89,247 | 20,774 | D |
| Open-market sales · 10,000 sh · avg $176.05 · $1,760,479 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2021-02-01 | Exercise or conversion : show line 7 in the form Stock Option (right to buy) | −10,000 | $5.04 | 2028-11-02 | 10,000 | 460,159 | D |
Loading xslF345X03/doc4.xml…